NCT06971627View on ClinicalTrials.gov

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 20, 2024

Primary Completion Date

July 20, 2024

Study Completion Date

May 30, 2025

Conditions
Inflammatory Bowel Disease (IBD)Medication ComplianceQuality of LifeTelehealth Monitoring
Interventions
BEHAVIORAL

Nurse-led Telehealth Monitoring Program

Participants in the intervention group will be included in a structured telehealth monitoring program led by a nurse for 12 weeks.

OTHER

No intervention

Participants in the control group will only receive standard care. No additional interventions will be implemented during the 12-week period.

Trial Locations (1)

34098

RECRUITING

Istanbul University - Cerrahpasa Cerrahpaşa Faculty of Medicine Department of Gastroenterology, Istanbul

All Listed Sponsors
lead

Istanbul University - Cerrahpasa

OTHER